.jpg)
2016 Spring CLU Highlights
PCSK9 Inhibitors: Practical Aspects of their use in Patients with Familial Hypercholesterolemia
James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA
Dr. James A. Underberg presents his talk at the 2015 Fall Clinical Lipid Update on PCSK9 Inhibitors: Practical Aspects of their use in Patients with Familial Hypercholesterolemia
Start Presentation Slides Audio OnlyTags:
Key Clinical Lipidology Publications: 2015-16
Kevin C. Maki, PhD, CLS, FNLA, FTOS, FACN
Dr. Kevin C. Maki presents his talk at the 2015 Fall Clinical Lipid Update on Key Clinical Lipidology Publications: 2015-16
Start Presentation Slides Audio OnlyTags:
Should PCSK9 Inhibitors be Used in Statin Intolerant Patients?
Terry A. Jacobson MD FACP FNLA
Dr. Terry A. Jacobson presents his talk at the 2015 Fall Clinical Lipid Update on Should PCSK9 Inhibitors be Used in Statin Intolerant Patients?
Start Presentation Slides Audio OnlyTags:
PCSK9 Inhibitors: Impact on the Management of LDL Apheresis Candidates and LDL Apheresis Patients
Anne Carol Goldberg, MD, FNLA
Dr. Anne Carol Goldberg presents her talk at the 2015 Fall Clinical Lipid Update on PCSK9 Inhibitors: Impact on the Management of LDL Apheresis Candidates and LDL Apheresis Patients
Start Presentation Slides Audio OnlyTags: